Navigation Links
DATATRAK Signs New Client for Rescue Study
Date:11/10/2009

clude the limited operating history on which the Company's performance can be evaluated; the ability of the Company to continue to enhance its software products to meet customer and market needs; fluctuations in the Company's quarterly results; the viability of the Company's business strategy and its early stage of development; the timing of clinical trial sponsor decisions to conduct new clinical trials or cancel or delay ongoing trials; the Company's dependence on major customers; government regulation associated with clinical trials and the approval of new drugs; the ability of the Company to compete in the emerging EDC market; losses that potentially could be incurred from breaches of contracts or loss of customer data; the inability to protect intellectual property rights or the infringement upon other's intellectual property rights; the costs associated with maintaining and/or developing two product suites; and general economic conditions such as the rate of employment, inflation, interest rates and the condition of capital markets. This list of factors is not all-inclusive. In addition, the Company's success depends on the outcome of various strategic initiatives it has undertaken, all of which are based on assumptions made by the Company concerning trends in the clinical research market and the health care industry. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.

SOURCE DATATRAK International, Inc.


'/>"/>
SOURCE DATATRAK International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. DATATRAK International, Inc. to Release 2009 Second Quarter and First-Half Operating Results on August 17, 2009
2. DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc.
3. Quantel Signs a Distribution Agreement With US-based National Biological
4. Global Med Technologies(R) Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product
5. Cell Biosciences Signs Agreement to Acquire Alpha Innotech
6. Fauve Intertrade Signs Major Energy Contracts in China
7. SynCo Bio Partners Enters the Japanese Market as it Signs its First Agreement With a Japanese Pharmaceutical Company
8. Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
9. Martek Signs Sole-Source ARA Supply Agreement with Puleva Food S.L.
10. Dendreon Signs Lease for New Manufacturing Facility in Atlanta
11. Alexandria Real Estate Equities, Inc. Signs Biopharmaceutical Company, Lilly, as Anchor New York City Tenant at the Alexandria Center for Science and Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 27, 2015 Junto Health, a company that ... and develop new technology solutions, today announced the launch ... a leader in health care policy consulting. Working together ... a collaborative innovation process while, at the same time, ... public policy, health care finance and the delivery of ...
(Date:7/26/2015)... , ... July 26, 2015 , ... ... its VALIDATE® ANEMIA calibration verification / linearity test kit. The VALIDATE® ANEMIA kit ... VALIDATE® ANEMIA kit is prepared using the CLSI recommended “equal delta” method for ...
(Date:7/24/2015)... ... 24, 2015 , ... VetStem Biopharma, proudly announces a new long term partnership ... training and clinical opportunities. , “We are very excited to be able to partner ... area. Stem cell therapy is an established treatment for arthritic conditions in our pets ...
(Date:7/24/2015)... SAN DIEGO , July 24, 2015 ... corporate and financial results for the second quarter 2015 ... the announcement, Orexigen will provide a business update and ... conference call at 8:00 a.m. Eastern Time (5:00 a.m. ... accessed by phone by calling (800) 447-0521 (domestic) or ...
Breaking Biology Technology:Junto Health Announces a Unique Partnership with Sachs Policy Group 2Junto Health Announces a Unique Partnership with Sachs Policy Group 3Junto Health Announces a Unique Partnership with Sachs Policy Group 4Maine Standards Company, LLC Announces Release of VALIDATE® ANEMIA Calibration Verification / Linearity Test Kit 2VetStem Biopharma, proudly announces a new long term partnership with VCA Emergency Animal Hospital & Referral Center. 2VetStem Biopharma, proudly announces a new long term partnership with VCA Emergency Animal Hospital & Referral Center. 3
... Mass., Oct. 5 Verenium Corporation (Nasdaq: VRNMD ... ethanol and high-performance specialty enzymes, today announced that it ... conditions, shares of its common stock, and potentially warrants, ... expected to price before 9:30 am EDT on Tuesday, ...
... ... (NEIRP) has announced it is a sponsor for this year’s 4th Annual Orthopedic Design ... October 6-8, 2009. NEIRP partners and staff will also be available to meet ... the benefits the region has to offer to the medical device industry . ...
... Oct. 5 PharmAthene, Inc. (NYSE Amex: ... against biological and chemical threats, today announced that ... Wright and Dr. Valerie Riddle, Vice President and ... Television Channel (HSTV) 30-minute documentary training video entitled, ...
Cached Biology Technology:Verenium Announces Proposed Public Offering of Common Stock 2Verenium Announces Proposed Public Offering of Common Stock 3Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design & Technology Conference & Exhibition 2Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design & Technology Conference & Exhibition 3PharmAthene Executives Featured in Anthrax Pathogen Training Video for U.S. Department of Homeland Security 2PharmAthene Executives Featured in Anthrax Pathogen Training Video for U.S. Department of Homeland Security 3
(Date:7/23/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/rzzp3v/global_outlook_of ) has ... of the Biometrics Industry 2015 " report ... biometrics market is likely to witness significant growth ... the uptake of multiple technologies available. The year ... growth of biometrics in existing applications as well ...
(Date:7/21/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology from ... also the user using unique personal identifiers including ...
(Date:7/20/2015)... 20, 2015  Acuity Market Intelligence,s latest research ... of Commerce and Privacy" forecasts that between 2014 ... will be downloaded to smart mobile devices by ... market is projected to generate more than $67.9 ... seven-year forecast period.    "Biometrics is ...
Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
... center called the National Resource for Network Biology (NRNB), ... of Medicine, will help clinicians analyze an ever-growing wealth ... real problems and diseases. In recent years, ... shifting much of their focus from single cells to ...
... PORTLAND, Ore. Oregon Health & Science University Doernbecher ... landmark clinical trial to further assess the safety and ... as a potential treatment for infantile or late-infantile neuronal ... disorder that affects infants and children. The Phase ...
... 28 October 2010 (Geneva, Switzerland) - A report issued ... Here, Right Now documents the principal debates around ... The report also takes stock of progress to date and ... and prevention at a time when new infections are outstripping ...
Cached Biology News:New center looks at how human systems function or fail 2New center looks at how human systems function or fail 3OHSU Doernbecher Children's Hospital conducts second phase of landmark Batten study 2New report underlines the threat to universal access to HIV prevention, treatment and care due to a slow-down in treatment scale-up and waning political will 2New report underlines the threat to universal access to HIV prevention, treatment and care due to a slow-down in treatment scale-up and waning political will 3
... Mouse monoclonal antibody raised ... Immunogen: ... 206 a.a) partial recombinant protein ... Accession Number: NM_005802 ...
Mouse monoclonal antibody raised against a partial recombinant PASK. NCBI Entrez Gene ID = PASK...
Agarose II (Low Melt)...
...
Biology Products: